Why Bio Rad Laboratories Inc’s (BIO) Stock Is Up 4.03%

By AAII Staff
January 26, 2024
Featured Tickers:
BIO

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Bio Rad Laboratories Inc before investing.

In this article, we go over a few key elements for understanding Bio Rad Laboratories Inc’s stock price such as:

  • Bio Rad Laboratories Inc’s current stock price and volume
  • Why Bio Rad Laboratories Inc’s stock price changed recently
  • Upgrades and downgrades for BIO from analysts
  • BIO’s stock price momentum as measured by its relative strength

About Bio Rad Laboratories Inc (BIO)

Before we jump into Bio Rad Laboratories Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Bio-Rad Laboratories, Inc. manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate chemical and biological materials and to identify, analyze and purify their components. The Company operates through two segments: Life Science and Clinical Diagnostics. Life Science segment markets and develops, manufactures and markets a portfolio of various products that serves a global customer base. The segment is focused on specific segments of the life sciences market in proteomics, genomics, biopharmaceutical production, cellular biology and food safety. Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. Its products address specific niches within the in vitro diagnostics (IVD) test market.

Want to learn more about Bio Rad Laboratories Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Bio Rad Laboratories Inc.

Learn More About A+ Investor

Bio Rad Laboratories Inc’s Stock Price as of Market Close

As of January 26, 2024, 4:00 PM, CST, Bio Rad Laboratories Inc’s stock price was $329.05.

Bio Rad Laboratories Inc is up 4.03% from its previous closing price of $316.30.

During the last market session, Bio Rad Laboratories Inc’s stock traded between $316.01 and $324.60. Currently, there are 29.10 million shares of Bio Rad Laboratories Inc stock available for purchase.

Unfortunately, Bio Rad Laboratories Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Bio Rad Laboratories Inc Stock Price History

Bio Rad Laboratories Inc’s (BIO) price is currently up 1.91% so far this month.

During the month of January, Bio Rad Laboratories Inc’s stock price has reached a high of $338.19 and a low of $302.65.

Over the last year, Bio Rad Laboratories Inc has hit prices as high as $509.62 and as low as $261.59. Year to date, Bio Rad Laboratories Inc’s stock is down 21.75%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Bio Rad Laboratories Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of January 25, 2024, there was 1 analyst who downgraded Bio Rad Laboratories Inc’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Bio Rad Laboratories Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Bio Rad Laboratories Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Bio Rad Laboratories Inc’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Bio Rad Laboratories Inc (BIO) by visiting AAII Stock Evaluator.

Relative Price Strength of Bio Rad Laboratories Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of January 25, 2024, Bio Rad Laboratories Inc has a weighted four-quarter relative price strength of -11.07%, which translates to a Momentum Score of 29 and is considered to be Weak.

Want to learn more about how Bio Rad Laboratories Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Bio Rad Laboratories Inc Stock Price: Bottom Line

As of January 26, 2024, Bio Rad Laboratories Inc’s stock price is $329.05, which is up 4.03% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Bio Rad Laboratories Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
O'Neil CAN SLIM Screen: 38.3% Compared to S&P 500
at only 23.3%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.